Rudolf Moser
46Patents
10h-index
36Co-inventors
75Inventor score
Filing activity: Nov 7, 1996 → Jan 25, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6441168B1 | Stable crystalline salts of 5-methyltetrahydrofolic acid | Human Necessities | 31 | Expired |
| US6544994B2 | Pharmaceutical preparation for treating or preventing cardiovascular or neurological disorders by modulating of the activity of nitric oxide synthase | Human Necessities | 27 | Expired |
| US6011040A | Use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine | Human Necessities | 26 | Expired |
| US7727987B2 | Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride | Human Necessities | 15 | Expired |
| US7566714B2 | Methods and compositions for the treatment of metabolic disorders | Human Necessities | 14 | Expired |
| US7732599B2 | Process for preparing tetrahydrobiopterin and analogs of tetrahydrobiopterin | Chemistry; Metallurgy | 13 | Active |
| US8067416B2 | Methods and compositions for the treatment of metabolic disorders | Human Necessities | 12 | Active |
| US8318745B2 | Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride | Human Necessities | 12 | Active |
| US9993481B2 | Methods and compositions for the treatment of metabolic disorders | Human Necessities | 11 | Active |
| US6271374A | Stable crystalline (6S)- and (6R)-tetrahydrofolic acid | Human Necessities | 11 | Expired |
| US9433624B2 | Methods and compositions for the treatment of metabolic disorders | Human Necessities | 10 | Active |
| US6995158B2 | Pharmaceutical preparation containing at least folic acid or a folate and tetrahydrobiopterin (BH4) or derivatives thereof used for the treating or preventing cardiovascular or neurological disorders by modulation of the activity of nitric oxide synthase (NOS) | Human Necessities | 9 | Expired |
| US5817659A | Stable crystalline tetrahydrofolic acid salts | Human Necessities | 8 | Expired |
| US6596721B2 | Stable crystalline (6R) -tetrahydrofolic acid | Human Necessities | 7 | Expired |
| US9180128B2 | Stable pharmaceutical compositions of 5,10-methylene tetrahydrofolate | Human Necessities | 7 | Active |
| US8344140B2 | 18F-labelled folates | Chemistry; Metallurgy | 4 | Active |
| US9295739B2 | Folate conjugates of albumin-binding entities | Chemistry; Metallurgy | 4 | Active |
| US6858731B1 | Process for the preparation of pure stereoisomers of tetrahydrofolic acid esters salts and tetrahydrofolic acid by fractionated crystallization of tetrahydrofolic acid esters salts | Chemistry; Metallurgy | 2 | Expired |
| US10570134B2 | Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid | Chemistry; Metallurgy | 2 | Active |
| US9771368B2 | 18F-labelled folates | Physics | 1 | Active |
| US10059710B2 | Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid | Chemistry; Metallurgy | 1 | Active |
| US11925644B2 | Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and l-leucine ethyl ester | Chemistry; Metallurgy | 1 | Active |
| US11992491B2 | Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and L-valine ethyl ester | Human Necessities | 1 | Active |
| US7816525B1 | Process for the preparation of optically pure tetrahydropterins and derivatives, and specifically of optically pure tetrahydrofolic acid and derivatives thereof, by stereospecific hydrogenation | Human Necessities | 1 | Expired |
| US10973936B2 | 18F-saccharide-folates | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.